BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29534945)

  • 1. Aceruloplasminemia and putaminal cavitation.
    Riboldi GM; Anstett K; Jain R; Lau H; Swope D
    Parkinsonism Relat Disord; 2018 Jun; 51():121-123. PubMed ID: 29534945
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurodegeneration With Brain Iron Accumulation: A Novel Mutation in the Ceruloplasmin Gene.
    Stelten BML; van Ommen W; Keizer K
    JAMA Neurol; 2019 Feb; 76(2):229-230. PubMed ID: 30383083
    [No Abstract]   [Full Text] [Related]  

  • 3. Extending the aceruloplasminemia phenotype: NBIA on imaging and acanthocytosis, yet only minor neurological findings.
    Kassubek R; Uttner I; Schönfeldt-Lecuona C; Kassubek J; Connemann BJ
    J Neurol Sci; 2017 May; 376():151-152. PubMed ID: 28431603
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
    Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aceruloplasminemia With Positive Ceruloplasm Gene Mutation.
    Kang HG; Kim M; Lee SC
    JAMA Ophthalmol; 2016 Jul; 134(7):e160816. PubMed ID: 27416276
    [No Abstract]   [Full Text] [Related]  

  • 6. Movement disorders and brain iron overload in a new subtype of aceruloplasminemia.
    Melgari JM; Marano M; Quattrocchi CC; Piperno A; Arosio C; Frontali M; Nuovo S; Siotto M; Salomone G; Altavilla R; di Biase L; Scrascia F; Squitti R; Vernieri F
    Parkinsonism Relat Disord; 2015 Jun; 21(6):658-60. PubMed ID: 25864092
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms.
    Rusticeanu M; Zimmer V; Schleithoff L; Wonney K; Viera J; Zimmer A; Hübschen U; Bohle RM; Grünhage F; Lammert F
    Clin Genet; 2014 Mar; 85(3):300-1. PubMed ID: 23557349
    [No Abstract]   [Full Text] [Related]  

  • 8. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for early identification of aceruloplasminemia.
    Ogimoto M; Anzai K; Takenoshita H; Kogawa K; Akehi Y; Yoshida R; Nakano M; Yoshida K; Ono J
    Intern Med; 2011; 50(13):1415-8. PubMed ID: 21720062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia?
    Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A
    Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753
    [No Abstract]   [Full Text] [Related]  

  • 12. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
    Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients.
    Vroegindeweij LHP; Langendonk JG; Langeveld M; Hoogendoorn M; Kievit AJA; Di Raimondo D; Wilson JHP; Boon AJW
    Parkinsonism Relat Disord; 2017 Mar; 36():33-40. PubMed ID: 28012953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Never forget aceruloplasminemia in case of highly suggestive Wilson's disease score.
    Kerkhof M; Honkoop P
    Hepatology; 2014 Apr; 59(4):1645-7. PubMed ID: 24002824
    [No Abstract]   [Full Text] [Related]  

  • 15. Effectiveness of oral iron chelator treatment with deferasirox in an aceruloplasminemia patient with a novel ceruloplasmin gene mutation.
    Suzuki Y; Yoshida K; Aburakawa Y; Kuroda K; Kimura T; Terada T; Kono S; Miyajima H; Yahara O
    Intern Med; 2013; 52(13):1527-30. PubMed ID: 23812204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of heterozygosis for aceruloplasminemia.
    Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aceruloplasminemia, a rare condition not to be overlooked].
    Lobbes H; Reynaud Q; Mainbourg S; Lega JC; Durieu I; Durupt S
    Rev Med Interne; 2020 Nov; 41(11):769-775. PubMed ID: 32682623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiological Findings of Two Sisters with Aceruloplasminemia Presenting with Chorea.
    Kim HK; Ki CS; Kim YJ; Lee MS
    Clin Neuroradiol; 2017 Sep; 27(3):385-388. PubMed ID: 28258281
    [No Abstract]   [Full Text] [Related]  

  • 19. Aceruloplasminemia presents as Type 1 diabetes in non-obese adults: a detailed case series.
    Vroegindeweij LH; van der Beek EH; Boon AJ; Hoogendoorn M; Kievit JA; Wilson JH; Langendonk JG
    Diabet Med; 2015 Aug; 32(8):993-1000. PubMed ID: 25661792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizures in Hereditary Aceruloplasminemia.
    Marano M; Bove F; Ricci L; Rohani M; Di Lazzaro V; Assenza G; Fasano A
    Can J Neurol Sci; 2021 Jan; 48(1):144-147. PubMed ID: 32741407
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.